AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
RBC Capital Lowers CYH Price Target to $5.00 from $6.00, Maintains "Outperform" Rating
ByAinvest
Sunday, Jul 27, 2025 5:42 am ET1min read
RBC Capital maintains "Outperform" rating for CYH but lowers price target from $6.00 to $5.00, representing a 16.67% decrease. The updated price target reflects RBC Capital's reassessment of CYH's market positioning while still indicating a positive outlook for the company's performance. The average target price for Community Health Systems Inc is $3.72 with a high estimate of $5.00 and a low estimate of $3.00, implying an upside of 30.25% from the current price of $2.86.
RBC Capital has revised its price target for Community Health Systems Inc (CYH) from $6.00 to $5.00, while maintaining an "Outperform" rating. The adjustment reflects the firm's concerns over CYH's lower-than-expected adjusted admissions in the second quarter, which has led to a cautious outlook for the remainder of the year. This development adds to existing volume-related worries for the company [1].Based on the one-year price targets offered by 8 analysts, the average target price for CYH is $3.72, with a high estimate of $5.00 and a low estimate of $3.00. This implies an average upside of 28.23% from the current price of $2.90 [1]. The consensus recommendation from 10 brokerage firms indicates a "Hold" status, with an average rating of 2.9 [1]. GuruFocus estimates the GF Value for CYH in one year to be $3.51, suggesting an upside of 21.03% from the current price of $2.9 [1].
CYH reported a 6.5% year-over-year increase in same-store net revenue for the second quarter but experienced a decline in adjusted admissions by 0.7%. Inpatient admissions increased by 0.3%, while same-store surgeries and emergency room visits declined by 2.5% and 1.9%, respectively. The company's adjusted EBITDA was $380 million, down from $387 million in the prior year period, and the EBITDA margin decreased to 12.1% from 12.3% [1].
RBC Capital's updated price target reflects the company's reassessment of CYH's market positioning while still indicating a positive outlook for its performance. The average target price for CYH is $3.72, with a high estimate of $5.00 and a low estimate of $3.00, implying an average upside of 30.25% from the current price of $2.86 [1].
References:
[1] https://www.gurufocus.com/news/3005142/community-health-cyh-price-target-reduced-by-rbc-capital-amid-volume-concerns-cyh-stock-news
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet